Lys160

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Ubiquitination Site Page:

Site Information

EAFEISKkEMQPTHP SwissProt Entrez-Gene

Predicted information: Scansite

Orthologous residues: 14‑3‑3 beta (human): K160, 14‑3‑3 beta (sheep): K123, 14‑3‑3 beta (rat): K160

Blast this site against: NCBI SwissProt PDB

In vivo Characterization

Methods used to characterize site in vivo:	mass spectrometry (1, 5)
Relevant cell line - cell type - tissue:	brain (1), kidney (1), liver (1), pooled tissues (1)

	References

1	Wagner SA, et al. (2012) Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol Cell Proteomics 11, 1578-85 22790023 Curated Info
2	(2010) CST Curation Set: 9134; Year: 2010; Biosample: PY2; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Curated Info
3	(2009) CST Curation Set: 8159; Year: 2009; Biosample: mouse spleen; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990 Curated Info
4	(2009) CST Curation Set: 8160; Year: 2009; Biosample: mouse testis; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990 Curated Info
5	(2008) CST Curation Set: 4126; Year: 2011; Biosample: AD+/-; Disease: Alzheimer's disease; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Curated Info

Home \| Curator Login	With enhanced literature mining using Linguamatics I2E		Produced by 3rd Millennium \| Design by Digizyme
			©2003-2013 Cell Signaling Technology, Inc.